PIRS Stock
Price Chart
PIRS Financial and Trading Overview
| stock price | 13.6 |
| Previous Close | 0.91 |
| Open | 0.89 |
| Bid | 0 x 1300 |
| Ask | 0 x 900 |
| Day's Range | 0.87 - 0.93 |
| 52 Week Range | 0.72 - 2.12 |
| Volume | 149.47K |
| Avg. Volume | 741.29K |
| Market Cap | 73.01M |
| Beta (5Y Monthly) | 1.078873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PIRS Valuation Measures
| Enterprise Value | 38.94M |
| Trailing P/E | N/A |
| Forward P/E | -1.2362499 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.3326535 |
| Price/Book (mrq) | 4.3 |
| Enterprise Value/Revenue | 2.311 |
| Enterprise Value/EBITDA | -0.795 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | 1.078873 |
| 52-Week Change | -46.70% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 2.12 |
| 52 Week Low | 0.72 |
| 50-Day Moving Average | 0.83 |
| 200-Day Moving Average | 1.14 |
PIRS Share Statistics
| Avg. Volume (3 month) | 741.29K |
| Avg. Daily Volume (10-Days) | 220.51K |
| Shares Outstanding | 82.02M |
| Float | 38.57M |
| Short Ratio | 1.29 |
| % Held by Insiders | 9.84% |
| % Held by Institutions | 59.36% |
| Shares Short | 1.85M |
| Short % of Float | 2.29% |
| Short % of Shares Outstanding | 2.25% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -245.45% |
| Operating Margin (ttm) | -305.80% |
| Gross Margin | -210.62% |
| EBITDA Margin | -290.78% |
Management Effectiveness
| Return on Assets (ttm) | -29.36% |
| Return on Equity (ttm) | -120.040% |
Income Statement
| Revenue (ttm) | 16.85M |
| Revenue Per Share (ttm) | 0.23 |
| Quarterly Revenue Growth (yoy) | -82.39% |
| Gross Profit (ttm) | -27080000 |
| EBITDA | -48998000 |
| Net Income Avi to Common (ttm) | -41359000 |
| Diluted EPS (ttm) | -0.54 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 48.38M |
| Total Cash Per Share (mrq) | 0.59 |
| Total Debt (mrq) | 13.09M |
| Total Debt/Equity (mrq) | 84.67 |
| Current Ratio (mrq) | 1.411 |
| Book Value Per Share (mrq) | 0.207 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -48285000 |
| Levered Free Cash Flow (ttm) | -23408000 |
Profile of
| Country | United States |
| State | MA |
| City | Boston |
| Address | 225 Franklin Street |
| ZIP | 02110 |
| Phone | 857 246 8998 |
| Website | https://www.pieris.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 127 |
Pieris Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops anticalin-based drugs. The company develops anticalin proteins that are low molecular-weight therapeutic proteins derived from lipocalins, which are naturally occurring low-molecular weight human proteins found in human blood plasma and other bodily fluids. Its lead respiratory Anticalin based drug candidate, elarekibep used for the treatment of asthma; and PRS-220, an oral inhaled Anticalin protein targeting connective tissue growth factor for the treatment of idiopathic pulmonary fibrosis. The company also develops PRS-344/S09501 2that consists of a PD-L1-targeting antibody and 4-1BB-targeting Anticalin proteins. It has a license and collaboration agreement with Les Laboratoires Servier and Institut de Recherches Internationales Servier, AstraZeneca AB, and Seagen Inc.; and license agreements with Technical University of Munich and Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. Pieris Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Boston, Massachusetts.
Q&A For Stock
What is a current PIRS stock price?
PIRS stock price today per share is 13.6 .
How to purchase stock?
You can buy PIRS shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is PIRS.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.
PIRS included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16307.16 USD — |
-3.07
|
7.08B USD — | 16066.46 USD — | 16600.37 USD — | — - | 7.08B USD — |
| NASDAQ Composite Total Return I XCMP | 19961.28 USD — |
-3.07
|
— — | 19666.65 USD — | 20320.18 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 99.3 USD — |
-2.27
|
— — | 98.11 USD — | 102.86 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 882.43 USD — |
-1.77
|
— — | 875.25 USD — | 895.82 USD — | — - | — — |
- {{ link.label }} {{link}}